6 quiz questions available for this topicTake Quiz
Itch - widespread
💡
Exam Tips
- In OSCE history, always ask duration (<6 weeks vs >=6 weeks), nocturnal pattern, new medications, travel/contacts, and constitutional B symptoms.
- Nocturnal generalized itch without rash should trigger consideration of uraemia and cholestasis, especially in renal/hepatology stations.
- Aquagenic itch after hot bathing is a classic exam clue for polycythaemia vera.
- Primary exam finding may be absent; secondary lesions (excoriations, lichenification, prurigo nodules) can mask original dermatosis.
- Baseline bloods for unexplained widespread itch: FBC/film, LFT, renal profile, ferritin/iron, CRP/ESR; then targeted tests (TFT, HbA1c, viral serology, CXR).
- Short-term antihistamine trials are for symptom relief; persistent or red-flag presentations require directed specialist referral rather than repeated empirical prescribing.
Definition
Widespread itch (generalized pruritus) is an unpleasant, poorly localized skin sensation that provokes an urge to scratch and may occur with little or no primary rash. In clinical practice it is classified as acute (<6 weeks) or chronic (>=6 weeks), and chronic presentations should prompt assessment for systemic, drug-related, psychogenic, or occult malignant causes when dermatosis is not evident.
Pathophysiology
Pruritus arises from activation of specialized peripheral itch pathways (mainly unmyelinated C-fibres) and central processing in the spinal cord and brain. Histamine is only one mediator; non-histaminergic pathways (including cytokines such as IL-31, proteases, neuropeptides, keratinocyte-derived mediators, and endogenous opioidergic signalling) are often dominant in chronic systemic itch. In kidney disease, uraemic pruritus is multifactorial (immune dysregulation, xerosis, neuropathic sensitization, and altered opioid receptor balance), while in liver disease cholestatic pruritogens (for example bile acid-related signalling and autotaxin-lysophosphatidic acid pathways) are important; these mechanisms explain why antihistamines may help sleep but often do not fully suppress itch intensity.
Risk Factors
- Older age and xerosis (impaired skin barrier hydration)
- End-stage renal disease, especially long-term haemodialysis
- Cholestatic liver disease (for example PBC, PSC, cirrhosis)
- Haematological disease (iron deficiency, polycythaemia vera, lymphoma, myeloproliferative disorders)
- Endocrine/metabolic disease (diabetes, thyroid disease, hyperparathyroidism)
- Infection/infestation (scabies, HIV, hepatitis B/C, helminth infection)
- Drugs (opioids, ACE inhibitors, statins, digoxin, thiazides, calcium-channel blockers, topiramate, chloroquine, sulphonamides)
- Psychological morbidity (anxiety, depression, trauma-related stress, functional itch disorder)
- Menopause
- Personal or family history suggesting systemic disease
Clinical Features
Symptoms
- Generalized itch with or without visible primary rash
- Nocturnal worsening (classically seen in uraemia, cholestasis, and some psychogenic itch states)
- Aquagenic itch (after warm bath/shower) suggesting possible polycythaemia vera
- Crawling sensation (formication), which may indicate psychogenic/delusional infestation
- Burning dysaesthesia, raising neuropathic or lymphoproliferative differentials
- Sleep disturbance, fatigue, poor concentration, and reduced quality of life
- Psychological distress (anxiety, low mood, irritability)
- Constitutional symptoms such as fever, night sweats, or weight loss (red flags for malignancy)
Signs
- Xerosis and dry, cracked skin
- Secondary scratch lesions: excoriations, lichenification, prurigo nodules, lichen simplex changes
- Post-inflammatory hypo- or hyperpigmentation and possible atrophic scarring
- Signs of secondary bacterial infection (for example impetiginized excoriations)
- Dermographism (urticarial tendency/atopy/hypersensitivity clue)
- Jaundice, pallor, uraemic skin colour change
- Lymphadenopathy and/or hepatosplenomegaly
- Minimal primary skin signs despite severe itch in some infestations (for example scabies in immunocompromise); see figure references for excoriations and lichenification in standard dermatology atlases
Investigations
Full blood count and blood film:May show anaemia, eosinophilia, or haematological disorder (for example myeloproliferative pattern)
Liver function tests:Cholestatic pattern (raised ALP/GGT, bilirubin) supports hepatobiliary cause
Renal profile (urea, creatinine, eGFR, electrolytes):Reduced eGFR/uraemia suggests renal pruritus context
Serum ferritin and iron studies:Iron deficiency or iron loading disorders as systemic contributors
Inflammatory markers (CRP and/or ESR):Raised markers may indicate inflammatory, infective, or malignant process
Thyroid function tests:Hypo- or hyperthyroidism as potential underlying cause
HbA1c:Diabetes mellitus as associated systemic condition
Bone chemistry (including calcium, phosphate, PTH if indicated):Hypercalcaemia/hyperparathyroid patterns or CKD-mineral bone disorder clues
HIV and hepatitis B/C serology:Identifies infective systemic causes
Chest X-ray:May reveal mediastinal lymphadenopathy or other thoracic pathology linked to malignancy
Management
Lifestyle Modifications
- Regular emollient use as both moisturizer and soap substitute; avoid fragranced/irritant products
- Keep nails short, reduce scratching injury (cool compresses, cotton clothing, lukewarm showers)
- Identify and remove triggers (new drugs, overheating, stress, alcohol excess, possible infestations)
- Use an itch diary (timing, severity, triggers, response) to support diagnosis and follow-up
- Treat psychological comorbidity and sleep disruption early
- Manage identified underlying causes promptly and refer to dermatology/renal/hepatology/haematology when persistent or red flags present
Pharmacological Treatment
Topical emollient therapy
- Leave-on emollient frequently plus emollient soap substitute
- Menthol 0.5% or 1% in aqueous cream (trial if simple emollient inadequate)
First-line symptomatic treatment in primary care. Check adherence and application technique before escalating.
Non-sedating oral antihistamines (short trial, off-label for generalized itch)
- Cetirizine 10 mg orally once daily for 2-3 weeks
- Loratadine 10 mg orally once daily for 2-3 weeks
- Fexofenadine 180 mg orally once daily for 2-3 weeks
Evidence for non-histaminergic chronic itch is limited; continue only if clear benefit. Consider renal/hepatic dose cautions per BNF and avoid duplication with other antihistamines.
Sedating antihistamines for troublesome nocturnal itch (short term)
- Hydroxyzine 25 mg orally at night (adults) for 2-3 weeks
- Chlorphenamine 4 mg orally at night (adults and children, off-label for this indication) for 2-3 weeks
Warn about sedation, impaired driving, falls risk, and additive CNS depression with alcohol/opioids/benzodiazepines. Hydroxyzine carries QT-prolongation/torsades risk: avoid in known prolonged QT, significant bradycardia, electrolyte disturbance, or with other QT-prolonging drugs.
Not routinely recommended in primary care for generalized itch without specific indication
- Topical anaesthetics
- Topical antihistamines
- Crotamiton
- Calamine
- Topical capsaicin
- Topical corticosteroids (unless inflammatory dermatosis present)
- Topical calcineurin inhibitors (unless specialist-directed)
- Topical doxepin
- Oral corticosteroids
Avoid routine use due to limited benefit and safety concerns; seek specialist advice for refractory disease.
Complications
- Chronic insomnia and daytime fatigue
- Anxiety, depression, and reduced quality of life
- Social withdrawal, embarrassment, and stigma from visible scratch injury
- Cognitive effects (poor concentration/memory)
- Excoriations, lichenification, chronic prurigo/prurigo nodularis, lichen simplex chronicus
- Secondary bacterial skin infection (for example impetigo)
- Pigmentary change and scarring
Prognosis
Outcome depends on identifying and treating the cause: symptoms often improve when a reversible trigger (for example xerosis or medication) is corrected, but chronic idiopathic or systemic pruritus can be relapsing and require long-term multimodal care. Persistent unexplained itch warrants ongoing review because itch may precede overt systemic disease.
Sources & References
✅NICE Guidelines(1)
- Itch - widespread[overview]
📖Textbook References(20)
- David Randall PhD MRCP (Editor), John Booth PhD MRCP (Editor), K - Kumar and Clark's Clinical Medicine (2025, American Elsevier Publishing Co.) - libgen.li.pdf(pp. 1536)[context]
- David Randall PhD MRCP (Editor), John Booth PhD MRCP (Editor), K - Kumar and Clark's Clinical Medicine (2025, American Elsevier Publishing Co.) - libgen.li.pdf(pp. 1120, 1121)[context]
- David Randall PhD MRCP (Editor), John Booth PhD MRCP (Editor), K - Kumar and Clark's Clinical Medicine (2025, American Elsevier Publishing Co.) - libgen.li.pdf(pp. 1692)[context]
- Guyton and Hall Textbook of Medical Physiology (John E. Hall, Michael E. Hall) (Z-Library).pdf(pp. 457)[context]
- Guyton and Hall Textbook of Medical Physiology (John E. Hall, Michael E. Hall) (Z-Library).pdf(pp. 302, 303)[context]
- Guyton and Hall Textbook of Medical Physiology (John E. Hall, Michael E. Hall) (Z-Library).pdf(pp. 244)[context]
- Guyton and Hall Textbook of Medical Physiology (John E. Hall, Michael E. Hall) (Z-Library).pdf(pp. 472)[context]
- Guyton and Hall Textbook of Medical Physiology (John E. Hall, Michael E. Hall) (Z-Library).pdf(pp. 453)[context]
- Guyton and Hall Textbook of Medical Physiology (John E. Hall, Michael E. Hall) (Z-Library).pdf(pp. 721)[context]
- Guyton and Hall Textbook of Medical Physiology (John E. Hall, Michael E. Hall) (Z-Library).pdf(pp. 612)[context]
- Guyton and Hall Textbook of Medical Physiology (John E. Hall, Michael E. Hall) (Z-Library).pdf(pp. 489)[context]
- _OceanofPDF.com_Netters_Anatomy_-_8th_edition_-_Frank_H_Netter_MD.pdf(pp. 3013)[context]
- [Oxford Medical Handbooks] Ian Wilkinson, Tim Raine, Kate Wiles, Anna Goodhart, Catriona Ha - Oxford Handbook of Clinical Medicine (2017, Oxford University Press) - libgen.li.pdf(pp. 169, 170)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1276, 1277)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1342)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1050)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1201)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1058)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 1058)[context]
- [Williams, Bailey and Love's Short Practice of Surgery] Norman Williams, Christopher Bulstrode, P Ronan O'Connell - Bailey & Love's Short Practice of Surgery 26E (2013, CRC Press) - libgen.li.pdf(pp. 569)[context]